From:
(HR)
To:
(HR)
Subject:
FW: EFPIA COVID-19 Situational assessment to 6 October 2020
Date:
jeudi 8 octobre 2020 16:34:37
Attachments:
EMA - COVID-19 EFPIA Situational Assessment 6 October 2020.docx
~WRD000.jpg
From:
@efpia.eu>
Sent: Tuesday, October 6, 2020 5:47 PM
To:
(EMA)
<
@ema.europa.eu>;
(EMA) <
@ema.europa.eu>;
(EMA) <
@ema.europa.eu>
Cc: RYS Andrzej Jan (SANTE)
@ec.europa.eu>;
(SANTE)
@ec.europa.eu>;
@efpia.eu>;
@efpia.eu>;
@efpia.eu>;
@emea.europa.eu; KYRIAKIDES Stella
(CAB-KYRIAKIDES)
@ec.europa.eu>;
BRETON Thierry (CAB-BRETON)
@ec.europa.eu>; LENARCIC Janez (CAB-
LENARCIC)
@ec.europa.eu>;
@merck.com>;
@astrazeneca.com>;
@pfizer.com>; M
vaccineseurope.eu>;
@gsk.com>; GALLINA Sandra
(SANTE)
@ec.europa.eu>;
CAB-KYRIAKIDES)
@ec.europa.eu>
Subject: EFPIA COVID-19 Situational assessment to 6
October 2020
Dear
and M
I hope this email finds you well. Please find attached our EFPIA
briefing in preparation for tomorrow's call.
The following EFPIA staff will attend the meeting tomorrow:
We will be joined by three company experts:
, MSD (
),
, AstraZeneca
(
) and
, Pfizer (
).
(Vaccines Europe) and
, GSK
(Vaccines) will also attend the meeting and I have included all in
cc to this email. I am sorry not to be able to attend the call in
person tomorrow due to another engagement.
This is a slightly updated version compared to that which we sent
Commissioners Kyriakides and Breton after the call last week,
most notably under point 2 where we are observing with great
concern that a number of stockpiling requirements are being
shepherded through the legislative process in countries such as
Estonia, France, the Netherlands or Portugal. I hope you won't
mind if I took the initiative to copy this mail to the
Commissioners and to DG SANTE colleagues.
My Team and I remain at your entire disposal for any further
information and look forward to continuing to make progress on
tomorrow's call.
Thank you and very best wishes,
EFPIA - European Federation of Pharmaceutical Industries and
Associations
Leopold Plaza Building
Rue du Trône 108
B-1050 Bruxelles
(Direct Line)
Tel: +3226262555 (Switchboard)
efpia.eu
www.efpia.eu
For more information related to COVID-19
see: https://efpia.eu/news-events/the-efpia-
view/statements-press-releases/european-
pharmaceutical-industry-response-to-
coronavirus/